JP2012523460A5 - - Google Patents

Download PDF

Info

Publication number
JP2012523460A5
JP2012523460A5 JP2012506113A JP2012506113A JP2012523460A5 JP 2012523460 A5 JP2012523460 A5 JP 2012523460A5 JP 2012506113 A JP2012506113 A JP 2012506113A JP 2012506113 A JP2012506113 A JP 2012506113A JP 2012523460 A5 JP2012523460 A5 JP 2012523460A5
Authority
JP
Japan
Prior art keywords
cirp
antibody
pharmaceutical composition
disease
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012506113A
Other languages
English (en)
Japanese (ja)
Other versions
JP5625043B2 (ja
JP2012523460A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/030824 external-priority patent/WO2010120726A1/en
Publication of JP2012523460A publication Critical patent/JP2012523460A/ja
Publication of JP2012523460A5 publication Critical patent/JP2012523460A5/ja
Application granted granted Critical
Publication of JP5625043B2 publication Critical patent/JP5625043B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012506113A 2009-04-13 2010-04-13 低温誘導性ｒｎａ結合タンパク質（ｃｉｒｐ）を阻害することによる炎症性疾患の治療 Expired - Fee Related JP5625043B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21258409P 2009-04-13 2009-04-13
US61/212,584 2009-04-13
PCT/US2010/030824 WO2010120726A1 (en) 2009-04-13 2010-04-13 Treatment of inflammatory diseases by inhibiting cold- inducible rna-binding protein (cirp)

Publications (3)

Publication Number Publication Date
JP2012523460A JP2012523460A (ja) 2012-10-04
JP2012523460A5 true JP2012523460A5 (enExample) 2013-05-30
JP5625043B2 JP5625043B2 (ja) 2014-11-12

Family

ID=42341280

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012506113A Expired - Fee Related JP5625043B2 (ja) 2009-04-13 2010-04-13 低温誘導性ｒｎａ結合タンパク質（ｃｉｒｐ）を阻害することによる炎症性疾患の治療

Country Status (8)

Country Link
US (2) US8703138B2 (enExample)
EP (1) EP2419134B1 (enExample)
JP (1) JP5625043B2 (enExample)
CN (1) CN102458465B (enExample)
AU (1) AU2010236670B2 (enExample)
CA (1) CA2758449C (enExample)
IL (1) IL215758A (enExample)
WO (1) WO2010120726A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2758449C (en) 2009-04-13 2021-11-30 The Feinstein Institute For Medical Research Treatment of inflammatory diseases by inhibiting cold-inducible rna-binding protein (cirp)
US9957295B2 (en) 2013-09-24 2018-05-01 The Feinstein Institute For Medical Research Peptides inhibiting cold-inducible RNA binding protein activity
ES2913339T3 (es) * 2014-01-31 2022-06-01 Draka Elevator Products Inc Dispositivo sensor de detección sísmica para equipo de transporte vertical
CN105582525B (zh) * 2014-10-24 2019-08-06 佛山市龙杰生物科技有限公司 Cirp在制备端粒酶结合剂或端粒酶活性调控剂方面的应用
US11001608B2 (en) 2019-07-11 2021-05-11 King Faisal University Arid5a peptide inhibitors
CN115925997B (zh) * 2022-11-16 2023-09-12 南通大学 一种干预治疗脑出血的多肽及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919661A (en) * 1997-08-25 1999-07-06 Incyte Pharmaceuticals, Inc. Polynucleotides encoding cytokine inducible regulatory protein
JPH11199507A (ja) * 1998-01-09 1999-07-27 Chugai Pharmaceut Co Ltd 脳疾患及び神経疾患治療薬
WO2001009387A1 (en) * 1999-07-29 2001-02-08 Northeastern University Isolation of novel hemapoietic genes by representational difference analysis
US7317077B2 (en) * 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
CN1980649A (zh) * 2004-05-17 2007-06-13 康宾纳特克斯公司 治疗免疫炎性疾病的方法和试药
WO2009090287A1 (es) * 2008-01-17 2009-07-23 Fundació Institut de Recerca de L'Hospital Universitari Vall d'Hebron Compuestos antitumorales basados en cirp
CA2758449C (en) 2009-04-13 2021-11-30 The Feinstein Institute For Medical Research Treatment of inflammatory diseases by inhibiting cold-inducible rna-binding protein (cirp)
US20140193412A1 (en) 2013-01-10 2014-07-10 The Feinstein Institute For Medical Research Treatment of cutaneous wounds by inhibiting cold shock proteins

Similar Documents

Publication Publication Date Title
JP2012523460A5 (enExample)
JP2020503885A5 (enExample)
JP2010511056A5 (enExample)
JP2016536347A5 (enExample)
JP2015525768A5 (enExample)
JP2018023398A5 (enExample)
JP2009515982A5 (enExample)
JP2014525735A5 (enExample)
JP2010273685A5 (enExample)
JP2012519489A5 (enExample)
JP2013509879A5 (enExample)
WO2011039508A3 (en) T-cell receptor
RU2018132044A (ru) Антитела против тау
JP2021507690A5 (enExample)
JP2017515909A5 (enExample)
JP2013538791A5 (enExample)
RU2492182C3 (ru) ГИДРОФОБНЫЕ, МОДИФИЦИРОВАННЫЕ, ПОЛУЧЕННЫЕ ИЗ preS ВИРУСА ГЕПАТИТА В (HBV) ПЕПТИДЫ И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ПРОНИКНОВЕНИЯ HBV И HDV
JP2012531922A5 (ja) Ｔｏｌｌ様受容体２へのヒト化抗体またはその抗原結合部位
WO2008005880A3 (en) Antibodies for norovirus
JP2012505657A5 (enExample)
Ohtani et al. Variable domain antibodies specific for viral hemorrhagic septicemia virus (VHSV) selected from a randomized IgNAR phage display library
RU2015154792A (ru) Выделенный антиген лейкоцидина Staphylococcus aureus, антитело, специфически связывающееся с субъединицей LukGH и способ определения связывания или токсичности двухкомпонентного цитолизина LukGH Staphylococcus aureus
CN102746403A (zh) 用于elisa检测黄曲霉毒素的标准品通用替代物、其制备方法及黄曲霉毒素elisa检测方法
JP2016513471A5 (enExample)
WO2012114125A3 (en) Treatment and prevention of malaria